EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) BASED ON SEVERITY OF HYPERTENSION: THE TRINITY STUDY

被引：1

作者：

Kereiakes, D. ^{[1
]}

Chrysant, S. G. ^{[2
,3
]}

Melino, M. ^{[4
]}

Fernandez, V. ^{[4
]}

Lee, J. ^{[4
]}

Heyrman, R. ^{[4
]}

机构：

[1] Christ Hosp Heart & Vasc Center, Lindner Res Ctr, Cincinnati, OH USA

[2] Oklahoma Cardiovasc & Hypertens Ctr, Oklahoma City, OK USA

[3] Univ Oklahoma, Coll Med, Oklahoma City, OK 73190 USA

[4] Daiichi Sankyo Inc, Parsippany, NJ USA

来源：

JOURNAL OF HYPERTENSION | 2010年 / 28卷

关键词：

D O I：

10.1097/01.hjh.0000378488.65027.ff

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：E97 / E97

页数：1

共 50 条

[1] EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION: THE TRINITY STUDY
Oparil, S.
Melino, M.
Fernandez, V.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2010, 28 : E101 - E101
[2] EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) BASED ON RACE: THE TRINITY STUDY
Littlejohn, T.
Melino, M.
Fernandez, V.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2010, 28 : E99 - E100
[3] Efficacy and Safety of Combination Olmesartan Medoxomil (OM) plus Amlodipine Besylate (AML) plus Hydrochlorothiazide (HCTZ) in Patients with Hypertension and Diabetes (The TRINITY Study)
Oparil, Suzanne
John, Thomas Little
Melino, Michael
Fernandez, Victor
Lee, James
Heyrman, Reinilde
DIABETES, 2010, 59 : A183 - A183
[4] SAFETY AND TOLERABILITY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION: THE TRINITY STUDY
Chrysant, S. G.
Oparil, S.
Melino, M.
Fernandez, V.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2010, 28 : E97 - E98
[5] EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION ANALYZED BY AGE AND GENDER: THE TRINITY STUDY
Chrysant, S. G.
Melino, M.
Fernandez, V.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2010, 28 : E103 - E103
[6] EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN BLACK AND NON-BLACK PATIENTS: THE TRINITY STUDY
Oparil, S.
Littlejohn, T.
Melino, M.
Fernandez, V.
Lee, J.
Heyrman, R.
ETHNICITY & DISEASE, 2010, 20 (04) : S39 - S39
[7] Efficacy and Safety of Combination Olmesartan Medoxomil (OM) plus Amlodipine Besylate (AML) plus Hydrochlorothiazide (HCTZ): A Subgroup Analysis by Ethnicity and BMI
Littlejohn, Thomas
Oparil, Suzanne
Melino, Michael
Fernandez, Victor
Lee, James
Heyrman, Reinilde
DIABETES, 2010, 59 : A560 - A560
[8] Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension
Ram, C. Venkata S.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (01) : 9 - 19
[9] Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Compared with Benazepril and Amlodipine Besylate
Dean J. Kereiakes
Joel M. Neutel
Henry A. Punzi
Jianbo Xu
Leslie J. Lipka
Robert Dubiel
American Journal of Cardiovascular Drugs, 2007, 7 : 361 - 372
[10] Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate
Kereiakes, Dean J.
Neutel, Joel M.
Punzi, Henry A.
Xu, Jianbo
Lipka, Leslie J.
Dubiel, Robert
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (05) : 361 - 372

← 1 2 3 4 5 →